Kaneka Issues Social Bond
KANEKA CORPORATION
August 17, 2026
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) will issue its 10th unsecured straight bond, "Social Bond," to raise funds related to the construction of a new plant for medical catheters (*1) at its Tomatoh Manufacturing Site in Hokkaido. The offering amount is 10 billion yen and the issuance term is 5 years, with issuance scheduled for September 2026.August 17, 2026
In our Medical business, we provide various innovations through medical devices including endovascular catheters and blood purification devices to solve social issues related to health.
This social bond is planned to be used for capital-investment expenditures at the new catheter plant currently under construction at the Company's Tomatoh Manufacturing Site. This investment will approximately double the current catheter production capacity.
Against the backdrop of a worldwide increase in the number of patients with the three major diseases (heart disease, cerebrovascular disease, and cancer) driven by the progression of population aging, mainly in developed countries, demand is growing for surgeries using medical catheters, which impose less burden on patients. By securing this supply base through the capacity expansion, we will meet the growing demand.
Based on our mission of KANEKA thinks “Wellness First”, we will realize a world where advanced medical care is accessible to everyone and where science contributes to the innovation of the global environment and our daily lives. From Tomakomai, "Kaneka, the Dream Factory" will make this vision a reality.
<Outline of the Social Bond>
・Name: Kaneka Corporation 10th unsecured straight bond
・Issuer: Kaneka Corporation
・Issuance amount: 10 billion yen (scheduled)
・Issuance term: 5 years (scheduled)
・Issuance date: September 2026 (scheduled)
・Lead managers: Nomura Securities Co., Ltd., SMBC Nikko Securities Inc., Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Daiwa Securities Co., Ltd.
・Structuring agent (*2): Nomura Securities Co., Ltd.
・Usage of funds: Capital investment at the Hokkaido Medical Device Plant
Eligibility as a social bond:
In issuing this social bond, we have updated part of our Social Finance Framework, established in November 2023, in accordance with the Social Bond Principles (SBP) 2025 of the International Capital Markets Association (ICMA), the Social Loan Principles (SLP) 2025 of the Loan Market Association (LMA), the Asia-Pacific Loan Market Association (APLMA), and the Loan Syndication and Trading Association (LSTA), as well as the Social Bond Guidelines (2021 edition) of the Financial Services Agency of Japan. As a third-party evaluation, we have obtained a second opinion from Rating and Investment Information, Inc. to the effect that the framework conforms to these principles.
(*1) Kaneka to Construct New Catheter Plant in Hokkaido – Roughly 10 Billion Yen Investment to Expand Medical Business Globally –
https://www.kaneka.co.jp/en/topics/news/2024/ennr2411071.html
(*2) A party that provides fundraising support through advice on the development of the Social Finance Framework and the acquisition of external third-party evaluations such as a second-party opinion.
https://www.kaneka.co.jp/en/topics/news/2024/ennr2411071.html
(*2) A party that provides fundraising support through advice on the development of the Social Finance Framework and the acquisition of external third-party evaluations such as a second-party opinion.
